TREM-1 and TREM-2 Expression on Blood Monocytes Could Help Predict Survival in High-Grade Glioma Patients

• Hauptverfasser: K. Kluckova (VerfasserIn), J. Kozak (VerfasserIn), K. Szaboova (VerfasserIn), B. Rychly (VerfasserIn), M. Svajdler (VerfasserIn), M. Suchankova (VerfasserIn), E. Tibenska (VerfasserIn), B. Filova (VerfasserIn), J. Steno (VerfasserIn), V. Matejcik (VerfasserIn), M. Homolova (VerfasserIn), M. Bucova (VerfasserIn)
• Format: Buch
• Veröffentlicht: Hindawi Limited, 2020-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Objective. In recent years, the role of the modern inflammatory markers TREM-1 (triggering receptors expressed on myeloid cells) and HMGB1 (high mobility group box 1 protein) in tumorigenesis has begun to be studied. Their role in gliomas is not clear. The aim of our study was to find the role of in...